Global Next Generation Cancer Diagnostics Market 2020: Development of cluster chip technology and potential applications of CTC in cancer management

Current Trend & Market Drivers: Increasing Demand for Companion Diagnostics, Customized Medicines Gaining Popularity, Recent Technological Developments of Next Generation Cancer Diagnostics, Exponentially decreasing cost of genetic sequencing, Rising demand for preventive medicine & companion diagnostics, Growing cancer incidence

Global Next Generation Cancer Diagnostics Market to reach USD 14.5 billion by 2025.

Get Free PDF Sample Brochure @ https://decisionmarketreports.com/request-sample/1074162

Global Next Generation Cancer Diagnostics Market is valued at approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more précised prognosis of various types of cancer, the next-generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth. 

The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values for the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the global infertility treatment market are given below:

Technology:

 NGS-based cancer diagnostics

 qPCR & Multiplexing

 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)

 Protein microarrays-based cancer diagnostics

 DNA microarrays-based cancer diagnostics

Know more about research methodology @ https://decisionmarketreports.com/request-methodolgy/1074162

Type:

 Lung Cancer  Breast Cancer  Colorectal Cancer  Cervical Cancer o Others

Applications:

 Biomarker Development  CTC Analysis  Proteomic Analysis  Epigenetic Analysis  Genetic Analysis

Functions:

 Therapeutic Monitoring  Companion Diagnostics  Prognostic Diagnostics  Cancer Screening  Risk Analysis

About Us

Decision Market Reports is a one-stop solution, covers market research studies of all the industries, companies and regions. DMR aims at providing quality research, and insights about every market to helps our clients in taking the right decisions. Our repository consists of most trending industry reports, niche areas, and leading company profiles. A comprehensive collection of reports is updated daily to offer hassle-free access to our latest updated report databases.

Contact Us

Gasper James

304, S Jones Blvd,

Las Vegas,

NV 89107, USA

US Toll-Free +18666051052

Email: sales@decisionmarketreports.com

Web: http://decisionmarketreports.com/

This content has been distributed via WiredRelease press release distribution service. For press release service enquiry, please reach us at contact@wiredrelease.com.